Does Arterio-Venous Fistula Creation Affects Development of Pulmonary Hypertension in Hemodialysis Patients?

REFERENCES

• Yigla M, Abassi Z, Reisner SA, Nakhoul F. Pulmonary hypertension in hemodialysis patients: an unrecognized threat. Semin Dial. 2006;19:353–357.
   PubMed Web of Science ®Google Scholar
• Rubin LJ. Pulmonary arterial hypertension. Proc Am Thorac Soc. 2006;3:111–115.
   PubMedGoogle Scholar
• Farber HW, Loscalzo J. Pulmonary arterial hypertension. N Engl J Med. 2004;351:1655–1665.
   PubMed Web of Science ®Google Scholar
• Yigla M, Nakhoul F, Sabag A, Pulmonary hypertension in patients with end-stage renal disease. Chest. 2003;123:1577–1582.
   PubMed Web of Science ®Google Scholar
• Acarturk G, Albayrak R, Melek M, The relationship between arteriovenous fistula blood flow rate and pulmonary artery pressure in hemodialysis patients. Int Urol Nephrol. 2008;40:509–513.
   PubMed Web of Science ®Google Scholar
• Amin M, Fawzy A, Hamid MA, Elhendy A. Pulmonary hypertension in patients with chronic renal failure: role of parathyroid hormone and pulmonary artery calcifications. Chest. 2003;124:2093–2097.
   PubMed Web of Science ®Google Scholar
• Tarrass F, Benjelloun M, Medkouri G, Hachim K, Benghanem MG, Ramdani B. Doppler echocardiograph evaluation of pulmonary hypertension in patients undergoing hemodialysis. Hemodial Int. 2006;10:356–359.
   PubMedGoogle Scholar
• Engelberts I, Tordoir JH, Boon ES, Schreij G. High-output cardiac failure due to excessive shunting in a hemodialysis access fistula: an easily overlooked diagnosis. Am J Nephrol. 1995;15:323–326.
   PubMed Web of Science ®Google Scholar
• MacRae JM, Levin A, Belenkie I. The cardiovascular effects of arteriovenous fistulas in chronic kidney disease: a cause for concern? Semin Dial. 2006;19:349–352.
   PubMedGoogle Scholar
• Marangoni S, Quadri A, Dotti A, Noninvasive assessment of pulmonary hypertension: a simultaneous echo-Doppler hemodynamic study. Cardiology. 1988;75:401–408.
   PubMedGoogle Scholar
• Dabestani A, Mahan G, Gardin JM, Evaluation of pulmonary artery pressure and resistance by pulsed Doppler echocardiography. Am J Cardiol. 1987;59:662–668.
   PubMed Web of Science ®Google Scholar
• Barst RJ, McGoon M, Torbicki A, Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol. 2004;43(12 Suppl. S):40S–47S.
   Web of Science ®Google Scholar
• Devereux RB, Wachtell K, Gerdts E, Prognostic significance of left ventricular mass change during treatment of hypertension. J Am Med Assoc. 2004;292:2350–2356.
   PubMed Web of Science ®Google Scholar
• Mosteller RD. Simplified calculation of body surface area. N Engl J Med. 1987;317:1098.
   PubMed Web of Science ®Google Scholar
• Rosenkranz S. Pulmonary hypertension: current diagnosis and treatment. Clin Res Cardiol. 2007;96:527–541.
   PubMed Web of Science ®Google Scholar
• Minai OA, Budev MM. Diagnostic strategies for suspected pulmonary arterial hypertension: a primer for the internist. Cleve Clin J Med. 2007;74:737–747.
   PubMed Web of Science ®Google Scholar
• Nakhoul F, Yigla M, Gilman R, Reisner SA, Abassi Z. The pathogenesis of pulmonary hypertension in hemodialysis patients via arterio-venous access. Nephrol Dial Transplant. 2005;20:1686–1692.
   PubMed Web of Science ®Google Scholar
• Giaid A, Yanagisawa M, Langleben D, Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med. 1993;328:1732–1799.
   PubMed Web of Science ®Google Scholar
• Giaid A, Saleh D. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med. 1995;333:214–221.
   PubMed Web of Science ®Google Scholar
• Havlucu Y, Kursat S, Ekmekci C, Pulmonary hypertension in patients with chronic renal failure. Respiration. 2007;74: 503–510.
   PubMed Web of Science ®Google Scholar
• MacRae JM. Vascular access and cardiac disease: is there a relationship? Curr Opin Nephrol Hypertens. 2006;15:577–582.
   PubMedGoogle Scholar
• Begin V, Ethier J, Dumont M, Leblanc M. Prospective evaluation of the intra-access flow of recently created native arteriovenous fistulae. Am J Kidney Dis. 2002;40: 1277–1282.
   PubMedGoogle Scholar
• Li JJ, Fang CH. C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular diseases. Med Hypotheses. 2004;62:499–506.
   PubMed Web of Science ®Google Scholar
• Rifai N, Ridker PM. High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease. Clin Chem. 2001;47:403–411.
   PubMed Web of Science ®Google Scholar
• Joppa P, Petrasova D, Stancak B, Tkacova R. Systemic inflammation in patients with COPD and pulmonary hypertension. Chest. 2006;130:326–333.
   PubMed Web of Science ®Google Scholar
• Elstein D, Nir A, Klutstein M, Rudensky B, Zimran A. C-reactive protein and NT-proBNP as surrogate markers for pulmonary hypertension in Gaucher disease. Blood Cells Mol Dis. 2005;34:201–215.
   PubMedGoogle Scholar
• Unal A, Sipahioglu MH, Oguz F, Pulmonary hypertension in peritoneal dialysis patients: the prevalence and risk factors. Perit Dial Int. 2009;29:191–198.
   PubMed Web of Science ®Google Scholar
• Ikizler TA. Nutrition, inflammation and chronic kidney disease. Curr Opin Nephrol Hypertens. 2008;17:162–167.
   PubMed Web of Science ®Google Scholar
• Caglar K, Peng Y, Pupim LB, Inflammatory signals associated with hemodialysis. Kidney Int. 2002;62:1408–1416.
   PubMed Web of Science ®Google Scholar
• Davies MR, Hruska KA. Pathophysiological mechanisms of vascular calcification in end-stage renal disease. Kidney Int. 2001;60:472–479.
   PubMedGoogle Scholar
• Bendayan D, Barziv Y, Kramer MR. Pulmonary calcifications: a review. Respir Med. 2000;94:190–193.
   PubMedGoogle Scholar
• Akmal M, Barndt RR, Ansari AN, Mohler JG, Massry SG. Excess PTH in CRF induces pulmonary calcification, pulmonary hypertension and right ventricular hypertrophy. Kidney Int. 1995;47:158–163.
   PubMedGoogle Scholar
• Kumbar L, Fein PA, Rafiq MA, Borawski C, Chattopadhyay J, Avram MM. Pulmonary hypertension in peritoneal dialysis patients. Adv Perit Dial. 2007;23:127–131.
   PubMedGoogle Scholar
• Yigla M, Keidar Z, Safadi I, Tov N, Reisner SA, Nakhoul F. Pulmonary calcification in hemodialysis patients: correlation with pulmonary artery pressure values. Kidney Int. 2004;66:806–810.
   PubMed Web of Science ®Google Scholar
• Abassi Z, Nakhoul F, Khankin E, Reisner SA, Yigla M. Pulmonary hypertension in chronic dialysis patients with arteriovenous fistula: pathogenesis and therapeutic prospective. Curr Opin Nephrol Hypertens. 2006;15:353–360.
   PubMed Web of Science ®Google Scholar
• Iwashima Y, Horio T, Takami Y, Effects of the creation of arteriovenous fistula for hemodialysis on cardiac function and natriuretic peptide levels in CRF. Am J Kidney Dis. 2002;40:974–982.
   PubMed Web of Science ®Google Scholar
• Ori Y, Korzets A, Katz M, Perek Y, Zahavi I, Gafter U. Hemodialysis arteriovenous access—a prospective hemodynamic evaluation. Nephrol Dial Transplant. 1996;11:94–97.
   PubMedGoogle Scholar
• Unger P, Velez-Roa S, Wissing KM, Hoang AD, van de Borne P. Regression of left ventricular hypertrophy after arteriovenous fistula closure in renal transplant recipients: a long-term follow-up. Am J Transplant. 2004;4:2038–2044.
   PubMed Web of Science ®Google Scholar
• Unger P, Wissing KM, de Pauw L, Neubauer J, van de Borne P. Reduction of left ventricular diameter and mass after surgical arteriovenous fistula closure in renal transplant recipients. Transplantation. 2002;74:73–79.
   PubMed Web of Science ®Google Scholar
• Lowrie EG, Lew NL. Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis. 1990;15:458–482.
   PubMed Web of Science ®Google Scholar
• Satoh K, Kagaya Y, Nakano M, Important role of endogenous erythropoietin system in recruitment of endothelial progenitor cells in hypoxia-induced pulmonary hypertension in mice. Circulation. 2006;113:1442–1450.
   PubMed Web of Science ®Google Scholar
• Weissmann N, Manz D, Buchspies D, Congenital erythropoietin over-expression causes “anti-pulmonary hypertensive” structural and functional changes in mice, both in normoxia and hypoxia. Thromb Hemost. 2005;94:630–638.
   PubMed Web of Science ®Google Scholar
• Hasegawa J, Wagner KF, Karp D, Altered pulmonary vascular reactivity in mice with excessive erythrocytosis. Am J Respir Crit Care Med. 2004;169:829–835.
   PubMedGoogle Scholar
• Briest W, Homagk L, Baba HA, Cardiac remodeling in erythropoietin-transgenic mice. Cell Physiol Biochem. 2004;14:277–284.
   PubMedGoogle Scholar